HealthCor Management’s NuVasive, Inc. NUVA Stock Holding History

HealthCor Management’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-969,580	Closed	-$54M	–	61
2020 Q2	$54M	Buy	+969,580	New	+$56.1M	2.26%	23
2019 Q4	–	Sell	-300,905	Closed	-$19.1M	–	69
2019 Q3	$19.1M	Buy	300,905 +51,185	+20%	+$3.2M	0.72%	37
2019 Q2	$14.6M	Buy	+249,720	New	+$14.7M	0.57%	41
2015 Q1	–	Sell	-750,000	Closed	-$35.4M	–	80
2014 Q4	$35.4M	Sell	750,000 -450,000	-38%	-$18.8M	1.97%	23
2014 Q3	$41.8M	Sell	1,200,000 -250,000	-17%	-$8.9M	2.15%	22
2014 Q2	$51.6M	Buy	1,450,000 +450,000	+45%	+$15.4M	2.59%	17
2014 Q1	$38.4M	Buy	1,000,000 +225,000	+29%	+$8.27M	2.31%	19
2013 Q4	$25.1M	Buy	775,000 +350,000	+82%	+$10.5M	1.52%	25
2013 Q3	$10.4M	Sell	425,000 -1,025,000	-71%	-$25.2M	0.56%	42
2013 Q2	$35.9M	Buy	+1,450,000	New	+$31.7M	2.17%	17

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

HealthCor Management's NUVA Position: Q3 2020 in Review

HealthCor Management sold out of NuVasive, Inc. (NUVA) in Q3 2020, closing a stake of 969,580 shares — an estimated $54M sold.

HealthCor Management first reported a position in NUVA in Q2 2013 and held it in 10 quarters. The position peaked at $54M in Q2 2020. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2020.

HealthCor Management reported no remaining NuVasive, Inc. position as of Q3 2020 after selling out during the quarter.
HealthCor Management sold 969,580 NuVasive, Inc. shares in Q3 2020, an estimated $54M.
HealthCor Management first reported a position in NuVasive, Inc. in Q2 2013 and held it in 10 quarters.
HealthCor Management's NuVasive, Inc. position peaked at $54M in Q2 2020.
263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2020.

Based on HealthCor Management's 13F filing for Q3 2020, filed 16 Nov 2020.